JP2003522185A5 - - Google Patents

Download PDF

Info

Publication number
JP2003522185A5
JP2003522185A5 JP2001557903A JP2001557903A JP2003522185A5 JP 2003522185 A5 JP2003522185 A5 JP 2003522185A5 JP 2001557903 A JP2001557903 A JP 2001557903A JP 2001557903 A JP2001557903 A JP 2001557903A JP 2003522185 A5 JP2003522185 A5 JP 2003522185A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
solubility tag
acid residues
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001557903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003522185A (ja
JP4896333B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/003813 external-priority patent/WO2001057072A2/en
Publication of JP2003522185A publication Critical patent/JP2003522185A/ja
Publication of JP2003522185A5 publication Critical patent/JP2003522185A5/ja
Application granted granted Critical
Publication of JP4896333B2 publication Critical patent/JP4896333B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001557903A 2000-02-07 2001-02-06 薬理活性抗ウイルスペプチドおよびそれらの使用法 Expired - Fee Related JP4896333B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18082300P 2000-02-07 2000-02-07
US60/180,823 2000-02-07
US18405700P 2000-02-22 2000-02-22
US60/184,057 2000-02-22
PCT/US2001/003813 WO2001057072A2 (en) 2000-02-07 2001-02-06 Pharmacologically active antiviral peptides and methods of their use

Publications (3)

Publication Number Publication Date
JP2003522185A JP2003522185A (ja) 2003-07-22
JP2003522185A5 true JP2003522185A5 (enExample) 2011-04-21
JP4896333B2 JP4896333B2 (ja) 2012-03-14

Family

ID=26876670

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001557903A Expired - Fee Related JP4896333B2 (ja) 2000-02-07 2001-02-06 薬理活性抗ウイルスペプチドおよびそれらの使用法

Country Status (9)

Country Link
US (3) US7371809B2 (enExample)
EP (1) EP1272510B1 (enExample)
JP (1) JP4896333B2 (enExample)
AT (1) ATE374208T1 (enExample)
AU (1) AU784264B2 (enExample)
CA (1) CA2399676C (enExample)
DE (1) DE60130641T2 (enExample)
ES (1) ES2293977T3 (enExample)
WO (1) WO2001057072A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE374208T1 (de) * 2000-02-07 2007-10-15 Wisconsin Alumni Res Found Pharmakologisch aktive antivirale peptide und methoden zu ihrer anwendung
AU2003210659A1 (en) * 2002-01-24 2003-09-02 Sangstat Medical Corporation Combination therapy for treatment of hiv infection
WO2005060541A2 (en) * 2003-12-01 2005-07-07 Wisconsin Alumni Research Foundation Peptides and methods for inducing cellular resistance to infection
JP4831410B2 (ja) 2006-02-28 2011-12-07 東亞合成株式会社 抗ウイルス性ペプチドおよび抗ウイルス剤
US9198965B2 (en) * 2008-06-13 2015-12-01 Wisconsin Alumni Research Foundation Peptide adjuvant for influenza vaccination
EP2310030A4 (en) 2008-06-13 2013-08-14 Wisconsin Alumni Res Found NEW ANTIVIRAL PEPTIDES AGAINST THE INFLUENZA VIRUS
CA2737774A1 (en) * 2008-09-19 2010-03-25 Henry Ford Health System Methods, systems, and compositions for calpain inhibition
GB201012651D0 (en) * 2010-07-28 2010-09-15 Univ Edinburgh Peptides
WO2012071549A2 (en) 2010-11-24 2012-05-31 Clontech Laboratories, Inc. Inducible expression system transcription modulators comprising a distributed protein transduction domain and methods for using the same
EP2668276A4 (en) * 2011-01-26 2014-04-23 Clontech Lab Inc Enhanced protein transduction
ES2444299B1 (es) 2012-08-23 2014-12-12 Nutrición Técnica Deportiva, S.L. Uso de un hidrolizado de caseina como agente antiherpético
AU2017415108A1 (en) * 2017-05-26 2019-12-19 Viramatix Sdn Bhd Peptides and uses therefor as antiviral agents
JP2024532615A (ja) * 2021-08-23 2024-09-05 アミトルクス セラピューティクス インコーポレイテッド 白血球特異的細胞透過性分子

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4814432A (en) 1987-05-22 1989-03-21 Merck & Co., Inc. Inhibitor of ribonucleotide reductase
US5260420A (en) * 1987-07-30 1993-11-09 Centre Regional De Transfusion Sanguine De Lille Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
US5104854A (en) * 1989-02-01 1992-04-14 Washington University Antiviral peptides
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
IT1231342B (it) * 1989-08-28 1991-11-28 Prodotti Antibiotici Spa Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono
JPH0421635A (ja) 1990-05-16 1992-01-24 Suntory Ltd アセトアルデヒドの毒性抑制剤およびアセトアルデヒドの毒性抑制に有効な飲食物
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections
JPH05310784A (ja) 1991-09-04 1993-11-22 Merck & Co Inc ヒト乳頭腫ウイルスタンパク質と網膜芽細胞腫遺伝子タンパク質との結合のペプチド阻害剤
ES2227542T3 (es) * 1993-11-03 2005-04-01 Clarion Pharmaceuticals, Inc. Parche hemostatico.
US5441936A (en) * 1993-12-07 1995-08-15 Houghten Pharmaceuticals, Inc. Antiviral peptides
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
FR2739621B1 (fr) 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
AU3982497A (en) 1996-07-30 1998-02-20 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Double-stranded rna dependent protein kinase derived peptides to promote proliferation of cells and tissues in controlled manner
US5877282A (en) * 1996-09-20 1999-03-02 Bristol-Myers Squibb Company Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
AU6972798A (en) * 1997-04-18 1998-11-13 University Of Medicine And Dentistry Of New Jersey Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
AU741546B2 (en) 1997-07-24 2001-12-06 Perseptive Biosystems, Inc. Conjugates of transporter peptides and nucleic acid analogs, and their use
FR2766826B1 (fr) * 1997-08-04 2001-05-18 Pasteur Institut Vecteurs derives d'anticorps pour le transfert de substances dans les cellules
EP1086126A1 (en) * 1998-06-10 2001-03-28 The Queen's University of Belfast Cell-permeable peptide
ATE374208T1 (de) 2000-02-07 2007-10-15 Wisconsin Alumni Res Found Pharmakologisch aktive antivirale peptide und methoden zu ihrer anwendung
WO2005060541A2 (en) 2003-12-01 2005-07-07 Wisconsin Alumni Research Foundation Peptides and methods for inducing cellular resistance to infection

Similar Documents

Publication Publication Date Title
JP2003522185A5 (enExample)
JP2005516885A5 (enExample)
JPH08504837A (ja) 新規ポリペプチドおよびこれから調製される抗ｈｉｖ剤
JPH05163298A (ja) 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
EP0528312A3 (en) Cyclic peptides and use thereof
JPH1072351A5 (enExample)
JP2005505579A5 (enExample)
EP0502198B1 (en) Novel polypeptide and anti-hiv drug prepared therefrom
JP2006506942A5 (enExample)
WO2004108938A3 (en) Peptide ligands of dendritic cells for nucleic acid vector targeting
CA2391333A1 (en) Sustained release formulation of a peptide and a copolymer
JP4808363B2 (ja) 新規ポリペプチド及びこれを含む抗ｈｉｖ剤
JPWO1992004374A1 (ja) 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
WO2004099240B1 (en) Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars)
CN102336815A (zh) 病毒感染的治疗
PT1417222E (pt) Polipéptidos isolados baseados no epítopo neutralizante da proteína p17 de vih, úteis como vacinas, e anticorpos antip17 neutralizantes que reconhecem especificamente o referido polipéptido neutralizante
CA2399676A1 (en) Pharmacologically active antiviral peptides and methods of their use
JP2006503088A5 (enExample)
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
WO2001027136A3 (fr) Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
US5622933A (en) Multiple branch peptide constructions for use against HIV
WO2007029262A3 (en) Compositions and methods using same for the detection of viruses
EP2990415A1 (en) Cyclic beta defensins analogs for the treatment of infections
JP2010511706A5 (enExample)
JP2006510360A5 (enExample)